IR Side Nav Overview Press Releases Events & Presentations Publications SEC Filings ESG Financial Reports Annual Reports Quarterly Reports Financial Calendar Corporate Governance Analyst Coverage Stock Information Share Repurchase Program Shareholder Fraud Warning Annual General Meeting Investor FAQ Media Materials Sign-up for Email Alerts Investor Contact Sylke Maas, Ph.D. VP Investor Relations & StrategySend Email +49 6131 9084-0 For U.S. Investors: Westwicke John WoolfordSend Email +1 443 213-0506 Media Contact Jasmina Alatovic Director Global External CommunicationsSend Email +49 6131 9084-0 EnglishGerman Update on COVID-19 Vaccine Program Press Conference December 2, 2020 Click here for webcast Supporting Materials Update on COVID-19 Vaccine Program Press Conference 7.2 MB
Click here for webcast Supporting Materials Update on COVID-19 Vaccine Program Press Conference 7.2 MB
